Ki20227
Ki-20227 is a potent and selective small molecule inhibitor of the c-Fms/CSF1R tyrosine kinase with an IC50 of 2 nM. It also exhibits activity against VEGFR2 and c-Kit/PDGFRβ. This inhibitor is a valuable research tool for studying tumor-associated macrophages, angiogenesis, and related oncogenic pathways in both cellular and animal models.
Product Specifications
CAS Number
623142-96-1
Product Name Alternative
CSF-1 receptor, CSF1R, CSF-1R, CD117, c-Fms, cFms, colony stimulating factor 1 receptor, cKit, c-Kit, Inhibitor, Platelet-derived growth factor receptor, Ki 20227, Ki-20227, Ki20227, inhibit, SCFR, PDGFR, Vascular endothelial growth factor receptor, VEGFR, VEGFR2
Field of Research
Cardiovascular Research, Signal Transduction
Purity
97.16% (May vary between batches)
Solubility
DMSO:55 mg/mL (114.45 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.16 mM)
Smiles
COc1cc (Oc2ccnc3cc (OC) c (OC) cc23) ccc1NC (=O) NC (C) c1nccs1
Molecular Formula
C24H24N4O5S
Molecular Weight
480.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62702R-BF350-01 20 µL
C7orf27 Recombinant Antibody, AbBy Fluor™ 350 Conjugated
Sign In for Pricing
View Details 
bsm-62702R-BF350-02 100 µL
C7orf27 Recombinant Antibody, AbBy Fluor™ 350 Conjugated
Sign In for Pricing
View Details 
sc-430030-LAC-2 200 µL
PCDHGA11 Lentiviral Activation Particles (m2)
Sign In for Pricing
View Details